Overview

Haleon is a multinational company working in consumer health. On 18 July 2022, Haleon was listed as an independent company on the London and New York stock exchanges. Haleon was established on 18 July 2022 as a corporate spin-off from GSK. The company has its headquartered in Surrey, UK. It is the largest consumer healthcare business in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company is a global leader in over-the-counter medicines with a 7.3 percent market share. The Group employs over 22,000 people across 170 markets, who are united by Haleon’s purpose - to deliver better everyday health to humanity. Haleon’s product portfolio spans five major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health, and Others. Its long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, Parodontax, and Centrum - are built on trusted science, innovation, and deep human understanding. The company enhanced its digital offering for Health Professionals leading to 3.6 million new users on the Haleon ‘HealthPartner’ portal and a total of 30,000 hours of webinar content engaged with.